PHARMAC have announced CGM funding for people with Type 1 diabetes from 1 October 2024. More detail to come.Additional information on Diabetes New Zealand website and the Pharmac Websites
You have nothing in your cart.
If you know the product code enter it here
If you know the product code enter it into the search field
Recombinant Human NGFR (TNFRSF16)-Fc Chimera (carrier-free), 100 μg
Recombinant Human NGFR (TNFRSF16)-Fc Chimera (carrier-free), 25 μg
Recombinant Human NGFR (TNFRSF16)-Fc Chimera (carrier-free), 500 μg
Recombinant Human Noggin (carrier-free), 20 μg
Recombinant Human Noggin (carrier-free), 5 μg
Recombinant Human NRG1 (Heregulin) EGF Domain (carrier-free), 100 μg
Recombinant Human NRG1 (Heregulin) EGF Domain (carrier-free), 25 μg
Recombinant Human NT-3 (Animal-Free), 10 μg
Recombinant Human NT-3 (carrier-free), 10 μg
Recombinant Human NT-3 (carrier-free), 2 μg
Recombinant Human NT-4 (carrier-free), 10 μg
Recombinant Human NT-4 (carrier-free), 2 μg
Recombinant Human NTRK2 (TrkB) (carrier-free), 10 µg
Recombinant Human NTRK2 (TrkB) (carrier-free), 100 µg
Recombinant Human Oncostatin M (Animal-Free), 10 μg
Recombinant Human Oncostatin M (carrier-free), 10 μg